Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Sees Large Growth in Short Interest

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 300 shares, a growth of 50.0% from the June 30th total of 200 shares. Based on an average daily volume of 1,900 shares, the short-interest ratio is currently 0.2 days.

Mosaic ImmunoEngineering Stock Down 5.2 %

Shares of OTCMKTS CPMV opened at $0.60 on Monday. Mosaic ImmunoEngineering has a twelve month low of $0.10 and a twelve month high of $0.87. The business has a fifty day simple moving average of $0.52 and a two-hundred day simple moving average of $0.50. The firm has a market cap of $4.33 million, a PE ratio of -4.60 and a beta of -0.02.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last released its quarterly earnings data on Tuesday, May 14th. The company reported ($0.04) earnings per share for the quarter.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.